Download | < Back |
13 Apr 2022 | |
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shailesh Siroya | |
View all announcements for BAL PHARMA LTD. | Source: BSE India |